| Patents for C12P 21 - Preparation of peptides or proteins (112,499) |
|---|
| 03/31/1994 | WO1994001547A3 A method for generation of antibodies to cell surface molecules |
| 03/31/1994 | WO1993023549A3 Nucleic acid corresponding to a gene of chromosome 22 involved in recurrent chromosomal translocations associated with the development of cancerous tumors |
| 03/31/1994 | CA2144856A1 A method of preventing tumor metastasis |
| 03/31/1994 | CA2144750A1 Tumor-specific antibodies and antigen |
| 03/31/1994 | CA2144651A1 Immortalized cells and uses therefor |
| 03/31/1994 | CA2123584A1 Attenuated, live vaccine for delaware strain ibdv |
| 03/31/1994 | CA2123406A1 Ikaros: a t cell pathway regulatory gene |
| 03/30/1994 | EP0589840A1 Reshaped monoclonal antibodies against an immunoglobulin isotype |
| 03/30/1994 | EP0589719A1 Modified platelet factor-4 |
| 03/30/1994 | EP0589487A1 Monoclonal antibodies for small organic molecules |
| 03/30/1994 | EP0588841A1 Method for production of a whey protein hydrolyzate. |
| 03/30/1994 | CN1084407A Method for producing clostridium perfringens vaccines |
| 03/29/1994 | US5298599 Fusion protein |
| 03/29/1994 | US5298596 Peptides and analogues and mixtures thereof for detecting and eliciting antibodies to rubella virus |
| 03/29/1994 | US5298489 DNA sequences recombinant DNA molecules and processes for producing lipocortins III, IV, V and VI |
| 03/29/1994 | US5298429 Monitoring transcription of reporter gene |
| 03/29/1994 | US5298420 Binds to peptide segment having thirteen amino acids |
| 03/29/1994 | US5298419 Diagnosis |
| 03/29/1994 | US5298409 Antibody-enhanced stereospecific hydrolyses |
| 03/29/1994 | US5298407 DNA encoding a protein active in lymphocyte-mediated cytotoxicity |
| 03/29/1994 | US5298402 Cell lines produced by transforming leukocytes of fish with oncogenes and physiologically active substances produced by the cell lines |
| 03/29/1994 | US5298400 Genetic engineering and gene expression |
| 03/29/1994 | US5298393 Monoclonal antibody for human acid-glutathione S-transferase and process for preparation thereof |
| 03/29/1994 | US5298391 Use of the SP-2 monoclonal antibody for the clinical diagnostics and for the monitoring of the HIV infection progress |
| 03/29/1994 | US5298244 Proteins for immunology |
| 03/29/1994 | CA2106693A1 Immunoassay for isothiazolones |
| 03/29/1994 | CA1328070C Purification process of bordetella bacteria protein antigens in order to obtain an acellular vaccine |
| 03/26/1994 | CA2106629A1 Modified platelet factor-4 |
| 03/23/1994 | EP0588750A2 Method for the production of recombinant polypeptides bearing epitopes from different hiv isolates, and their uses as immunogens and in the detection of antibodies against hiv |
| 03/23/1994 | EP0588642A1 Kainate-binding, human CNS receptors of the EAA5 family |
| 03/23/1994 | EP0588177A2 An interferon-alpha/beta binding protein, its preparation and pharmaceutical compositions containing it |
| 03/23/1994 | EP0588122A1 Improved antibodies to plasmodium falciparum |
| 03/23/1994 | EP0588118A2 Bone-related carboxypeptidase-like protein and process for its production |
| 03/23/1994 | EP0588036A2 Composition for isolating apamin receptors, apamin binding protein and uses thereof |
| 03/23/1994 | EP0587873A1 Process and culture medium for the production of cells infected by a multiple sclerosis associated virus |
| 03/23/1994 | EP0587806A1 Therapeutic and diagnostic methods based on neurotrophin-4 expression |
| 03/23/1994 | EP0587798A1 Insecticidal proteins and method for plant protection |
| 03/23/1994 | EP0587791A1 Enhancement of expression by gene targeting in endogenous retrovirus-like sequences |
| 03/23/1994 | EP0587771A1 Methods and compositions relating to genetically engineered cells that produce insulin in response to glucose |
| 03/23/1994 | EP0587765A1 Induction of immune response against tetanus toxin through administration of mycobacteria expressing tetanus toxin or fragments |
| 03/23/1994 | EP0587735A1 T cell receptor peptides as therapeutics for immune-related disease |
| 03/23/1994 | EP0587571A1 HUMAN GALANIN, cDNA CLONES ENCODING HUMAN GALANIN AND A METHOD OF PRODUCING HUMAN GALANIN |
| 03/23/1994 | EP0511978B1 Method of purifying recombinant polypeptides |
| 03/23/1994 | CN1084216A Method of intracellular binding of target molecules |
| 03/22/1994 | US5296383 Human centromere antigen polypeptide |
| 03/22/1994 | US5296352 Monoclonal antibodies directed against complexes formed by thrombin and hirudin |
| 03/17/1994 | WO1994005813A1 Compositions and methods for treatment of hepatitis c virus-associated diseases |
| 03/17/1994 | WO1994005811A1 CLONING AND EXPRESSION OF βAPP-C100 RECEPTOR |
| 03/17/1994 | WO1994005804A1 Maspin, a novel serpin with tumor suppressing activity |
| 03/17/1994 | WO1994005801A1 Monoclonal antibodies reactive with defined regions of the t cell antigen receptor |
| 03/17/1994 | WO1994005798A1 Process for the selective increase of production of antibiotic ge 2270 factor a |
| 03/17/1994 | WO1994005793A2 Dna sequences involved in soraphen biosynthesis by myxobacteria |
| 03/17/1994 | WO1994005792A1 Self-assembling recombinant papillomavirus capsid proteins |
| 03/17/1994 | WO1994005791A2 Dorsal tissue affecting factor and compositions |
| 03/17/1994 | WO1994005790A1 Cloning and sequencing of allergens of dermatophagoides (house dust mite) |
| 03/17/1994 | WO1994005789A1 Glucagon receptors |
| 03/17/1994 | WO1994005786A1 Production of heterodimer pdgf-ab by means of a bicistronic vector system in mammalian cells |
| 03/17/1994 | WO1994005785A1 Multicistronic expression units and their use |
| 03/17/1994 | WO1994005781A1 Phagemids coexpressing a surface receptor and a surface heterologous protein |
| 03/17/1994 | WO1994005699A1 Glucagon antagonists and methods for detecting glucagon antagonists |
| 03/17/1994 | WO1994005692A1 Antibodies specific for a haemostatic protein, their use for isolating intact protein, haemostatic compositions devoid of proteolytic cleavage products of the protein |
| 03/17/1994 | WO1994005691A1 Cd27 ligand |
| 03/17/1994 | WO1994005690A1 Novel antibodies for conferring passive immunity against infection by a pathogen in humans |
| 03/17/1994 | WO1994005304A1 Isolated nonapeptide derived from mage-3 gene and presented by hla-a1, and uses thereof |
| 03/17/1994 | WO1993025682A3 Chimeric receptor polypeptides, human h13 proteins and uses thereof |
| 03/17/1994 | CA2143678A1 Compositions and methods for treatment of hepatitis c virus-associated diseases |
| 03/17/1994 | CA2143417A1 Novel antibodies for conferring passive immunity against infection by a pathogen in humans |
| 03/17/1994 | CA2143188A1 Maspin, a novel serpin with tumor suppressing activity |
| 03/17/1994 | CA2143186A1 Monoclonal antibodies reactive with defined regions of the t cell antigen receptor |
| 03/17/1994 | CA2143007A1 Glucagon antagonists and methods for detecting glucagon antagonists |
| 03/16/1994 | EP0587312A2 Polypeptide production |
| 03/16/1994 | EP0587279A1 Human nucleic acid fragments isolated from brain, adrenal tissue, placenta or bone narrow and their use |
| 03/16/1994 | EP0586892A1 Production of Bacillus Entomotoxins in Methylotrophic Yeast |
| 03/16/1994 | EP0586790A1 Amyloid precursor-like protein and uses thereof |
| 03/16/1994 | EP0586687A1 Trans-sialidase and methods of use and making thereof |
| 03/16/1994 | EP0586657A1 Receptor for the glucagon-like-peptide-1 (glp-1) |
| 03/16/1994 | EP0586607A1 HEREGULINS (HRGs), BINDING PROTEINS OF P185?erb2 |
| 03/16/1994 | EP0586549A1 Selecting ligand agonists and antagonists |
| 03/16/1994 | EP0586505A1 Heteroconjugate antibodies for treatment of hiv infection |
| 03/16/1994 | EP0586445A1 Monoclonal antibodies against c-kit |
| 03/16/1994 | EP0586372A1 RECOMBINANT 21 kD COCOA PROTEIN AND PRECURSOR |
| 03/15/1994 | US5294699 Absorbers |
| 03/15/1994 | US5294552 Streptomyces |
| 03/15/1994 | US5294538 Enzyme inhibitor |
| 03/15/1994 | US5294537 Monoclonal antibody assay for Listeria monocytogenes |
| 03/15/1994 | CA1327762C Dna constructs containing a kluyveromyces alpha-factor leader sequence for directing secretion of heterologous polypeptides |
| 03/09/1994 | EP0586266A1 DNA fragments coding for the Neisseria meningitidis receptor fragments |
| 03/09/1994 | EP0586154A2 Melanin formation-inhibitory protein, and its preparation and uses |
| 03/09/1994 | EP0586094A1 Soluble LDL receptor and gene |
| 03/09/1994 | EP0586076A2 Recombinant adenovirus vaccines |
| 03/09/1994 | EP0586026A2 Characterization of a novel anti-p110 RB monoclonal antibody |
| 03/09/1994 | EP0586002A2 Monoclonal antibodies recognizing the epidermal growth factor receptor, cells and methods for their production and compositions containing them |
| 03/09/1994 | EP0585983A2 Nucleotide vector comprising a translation inhibition factor gene, and IRES region and a desired gene |
| 03/09/1994 | EP0585963A1 Monoclonal antibodies to CMP-170 antigen on activated endothelial cells |
| 03/09/1994 | EP0585943A2 Soluble ligands for CD40 |
| 03/09/1994 | EP0585939A2 TNF ligands |
| 03/09/1994 | EP0585801A2 Bone-related cadherin-like protein and process for its production |
| 03/09/1994 | EP0585767A2 Pseudomonas Lipase |
| 03/09/1994 | EP0585570A1 Antigranulocyte antibody construct, preparation and use thereof |
| 03/09/1994 | EP0585554A1 Process for preparing a transgenic plant expressing phytolacca antiviral protein |